| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 06/08/2006 | US20060123496 Animal models |
| 06/08/2006 | US20060123495 Knockout mice and their use |
| 06/08/2006 | US20060123494 Reconstituted human breast tumor model |
| 06/08/2006 | US20060123493 Reconstituted human breast tumor model |
| 06/08/2006 | US20060123492 Methods of identifying modulators of NMUR2-mediated activity |
| 06/08/2006 | US20060123491 Method for a (high through-put) screening detection of genetic modifications in genome engineering |
| 06/08/2006 | US20060123490 Pluripotent cells with improved efficiency of homologous recombination and use of the same |
| 06/08/2006 | US20060123489 Sex-specific automated sorting of non-human animals |
| 06/08/2006 | US20060123488 Avian eggs and exogenous proteins |
| 06/08/2006 | US20060123487 Methods of screening agents for activity using teleosts |
| 06/08/2006 | US20060122381 Recombinase mediated transcription |
| 06/08/2006 | US20060122372 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 06/08/2006 | US20060121465 Sgk and nedd used as diagnostic and therapeutic targets |
| 06/08/2006 | US20060121440 Low pressure sperm cell separation system |
| 06/08/2006 | US20060120963 Method of identifying therapeutic compounds for a treatment of hepatic disorders |
| 06/08/2006 | US20060118050 Method and housing assembly for farming members of the Phylum Arthropoda |
| 06/08/2006 | CA2590725A1 Sex-specific automated sorting of non-human animals |
| 06/07/2006 | EP1666595A1 GAB2 (P97) gene and methods of use thereof |
| 06/07/2006 | EP1664313A2 Excretable reporter systems |
| 06/07/2006 | EP1664294A2 Regulation of cardiac contractility and heart failure propensity |
| 06/07/2006 | EP1664281A1 Method for culturing avian spermatogonial stem cells and avian spermatogonial stem cells prepared thereby |
| 06/07/2006 | EP1663310A1 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiocascular disease caused thereby |
| 06/07/2006 | EP1662863A2 Transgenic tieg non-human animals |
| 06/07/2006 | EP1662862A1 Receptor |
| 06/07/2006 | EP1565564A4 Modified antibodies stably produced in milk and methods of producing same |
| 06/07/2006 | EP1352051B1 In vivo animal model of human leukemia |
| 06/07/2006 | EP1313849B1 Methods for producing cloned avians |
| 06/07/2006 | EP1038015B1 Mood disorder gene |
| 06/07/2006 | EP0813538B1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 06/07/2006 | CN1258563C Highly-neutralized ethylene copolymers and their use in golf balls |
| 06/06/2006 | US7057086 Treating eating, tumor, nervous system, systemic amyloidosis, myelofibrosis, glomerulosclerosis, atherosclerosis and age related disorders; animal models |
| 06/06/2006 | US7056885 Fibroblast growth factor and nucleic acids encoding same |
| 06/06/2006 | US7056720 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 06/06/2006 | US7056704 RNA interference mediating small RNA molecules |
| 06/06/2006 | US7056510 Streptococcus pneumoniae SP036 polynucleotides, polypeptides, antigens and vaccines |
| 06/01/2006 | WO2006057315A1 Feeding method and feeding device for raising natural enemy insect and method of raising natural enemy insect |
| 06/01/2006 | WO2006056769A1 Methods of studying tolerance in mhc-ii transgenic animals |
| 06/01/2006 | WO2006056663A1 Method of screening compounds for the treatment of diabetes |
| 06/01/2006 | WO2006056623A1 Ccr6-deficient mice or cells and modulation of inflammatory diseases |
| 06/01/2006 | WO2006056617A1 Gene trap cassettes for random and targeted conditional gene inactivation |
| 06/01/2006 | WO2006026238A3 Rna interference in avians |
| 06/01/2006 | WO2006008548A3 Binding molecules |
| 06/01/2006 | WO2005112968A3 Method of using recombinant human antithrombin for neurocognitive disorders |
| 06/01/2006 | WO2005041757A3 Detection of neuropeptides associated with pelvic pain disorders and uses thereof |
| 06/01/2006 | US20060117399 Animal model for human lymphomas |
| 06/01/2006 | US20060117398 Suppression of endogenous immunoglobulin expression |
| 06/01/2006 | US20060117397 Imaging modalities for screening Alzheimer's disease therapeutics |
| 06/01/2006 | US20060117396 Assay methods for identifying modulators of OPSDL3 and transgenic knockouts |
| 06/01/2006 | US20060117395 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 06/01/2006 | US20060117394 Chimeric cells coding heterologous immunoglobulin for treatment, prevention and diagnosis of infections and cell proliferative disorders |
| 06/01/2006 | US20060116506 Tenebrio antifreeze proteins |
| 06/01/2006 | US20060115895 Fish disease models and uses thereof |
| 06/01/2006 | US20060115853 Polynucleotides, polypeptides and method for screening for useful dog candidates |
| 06/01/2006 | CA2592637A1 Phytoseiid mite rearing methods and methods for biological pest control |
| 06/01/2006 | CA2589208A1 Gene trap cassettes for random and targeted conditional gene inactivation |
| 06/01/2006 | CA2589163A1 Methods of studying tolerance in mhc-ii transgenic animals |
| 05/31/2006 | EP1661994A1 Therapeutic agent for NGF |
| 05/31/2006 | EP1661984A1 Method of differentiation from embryo-stem cell of primate to hematogenous cell |
| 05/31/2006 | EP1661457A1 Method of constructing offspring originating from frozen sperm stem cell |
| 05/31/2006 | EP1661456A1 Method of constructing nuclear-transplanted egg, parthenogenetic embryo and parthenogenetic mammal |
| 05/31/2006 | EP1660662A1 Regulatable gene expression in mammalian cells and mammals |
| 05/31/2006 | EP1660114A1 Methods and compositions for treating disorders of the extracellular matrix |
| 05/31/2006 | EP1659860A1 New diabetes type 2 animal model |
| 05/31/2006 | EP1659859A1 Method for producing avian chimera using spermatogonial cells and avian chimera |
| 05/31/2006 | EP1659858A2 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP0689593B1 Inhibition of selected tumor growth with recombinant viral vector |
| 05/31/2006 | CN2783754Y Shed and gallow structure for outdoor rearing for silkworm |
| 05/31/2006 | CN2783753Y Device for breeding aquatic tubifex annelida |
| 05/31/2006 | CN1781019A Animal model simulating neurologic disease |
| 05/31/2006 | CN1780916A Chicken RNA polymerisate I promoter and the use thereof |
| 05/31/2006 | CN1780554A Clinically relevant animal model of human breast cancer and VEGF involvement in desmoplastic response, tamoxifen resistance and metastasis |
| 05/30/2006 | US7053263 Mouse models of human prostate cancer progression |
| 05/30/2006 | US7053262 Activation; transgenic rodent; genetic engineering |
| 05/30/2006 | US7053187 Sperm-specific monoclonal antibody, mAbC |
| 05/30/2006 | US7051672 System for providing beneficial insects or mites |
| 05/30/2006 | CA2378415C Worm food composition |
| 05/26/2006 | WO2006055597A1 Use of ribose-cysteine to treat hypoxia by enhancing delivery of glutathione and atp levels in cells |
| 05/26/2006 | WO2006054666A1 Chick lif protein and utilization thereof |
| 05/26/2006 | WO2006054326A2 Animal model for studying substances with cardiotherapeutic and anti-hypertensive activity |
| 05/26/2006 | WO2006054108A1 Maggot delivery system |
| 05/26/2006 | WO2006053788A2 Alterations in seborrheic keratoses and their applications |
| 05/26/2006 | WO2006053787A1 A non-human animal alzheimer’s disease model and uses thereof |
| 05/26/2006 | WO2006018736A3 Use of golden hamster as infectivity model of sars |
| 05/26/2006 | WO2005115478A3 Methods and compositions for autism spectrum disorders |
| 05/26/2006 | WO2005112619A3 Novel gene disruptions, compositions and methods relating thereto |
| 05/26/2006 | WO2005104836A3 Drosophila models for diseases affecting learning and memory |
| 05/26/2006 | CA2587616A1 Use of ribose-cysteine to treat hypoxia by enhancing delivery of glutathione and atp levels in cells |
| 05/26/2006 | CA2585308A1 A non-human animal alzheimer's disease model and uses thereof |
| 05/25/2006 | US20060112441 CYT28 serpentine receptor disruptions, compositions and methods relating thereto |
| 05/25/2006 | US20060112440 Fluorescent protein sensors for detection of analytes |
| 05/25/2006 | US20060112439 Delta opioid receptor disruptions, compositions and methods related thereto |
| 05/25/2006 | US20060112438 Novel culture systems for ex vivo development |
| 05/25/2006 | US20060112437 Transgenic animal expressing alzheimer's tau protein |
| 05/25/2006 | US20060110768 contacting a viable murine myoblast test cell with test compound, determining the change in expression level of a murine indicator gene selected from the group consisting of 4833427G06 Rik (RIKEN cDNA) and murine Dda3 (Differential display and activated by p53) |
| 05/25/2006 | US20060110377 Immunologically privileged cells and uses thereof |
| 05/25/2006 | US20060110362 Sequences upstream of the CARP gene, vectors containing them and uses thereof |
| 05/24/2006 | EP1659175A1 Alterations in seborrheic keratoses and their applications |
| 05/24/2006 | EP1658370A1 Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof |
| 05/24/2006 | EP1657977A1 Methods for maintaining genetic stability of inbred animal strains |